SHANGHAI JUNSHI BIO YC1 (8SJ) — Financial Flexibility Index
SHANGHAI JUNSHI BIO YC1 (8SJ) has a Financial Flexibility Index of 0.04x as of December 2025. Free cash flow of €253.78 Million (operating CF €-514.51 Million minus capex €768.30 Million) represents 0% of total liabilities (€6.33 Billion). Also explore SHANGHAI JUNSHI BIO YC1 (8SJ) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SHANGHAI JUNSHI BIO YC1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for SHANGHAI JUNSHI BIO YC1 across 5 annual periods. Check SHANGHAI JUNSHI BIO YC1 (8SJ) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for SHANGHAI JUNSHI BIO YC1 (2021–2025)
Year-by-year free cash flow to debt coverage for SHANGHAI JUNSHI BIO YC1. For the full company profile including market capitalisation, see SHANGHAI JUNSHI BIO YC1 market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | €253.78 Million | €-514.51 Million | €6.33 Billion | ▲ +125.9% |
| 2024 | -0.16x | €-751.85 Million | €-1.44 Billion | €4.85 Billion | ▲ +47.3% |
| 2023 | -0.29x | €-1.18 Billion | €-2.01 Billion | €4.02 Billion | ▲ +40.8% |
| 2022 | -0.50x | €-1.38 Billion | €-1.78 Billion | €2.78 Billion | ▼ -652.5% |
| 2021 | 0.09x | €244.33 Million | €-641.90 Million | €2.72 Billion | — |